Clinical Trial Detail

NCT ID NCT02624258
Title Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of Pennsylvania
Indications

Hodgkin's lymphoma

Therapies

RNA CART19 cells

Age Groups: adult

No variant requirements are available.